Should You Buy UiPath Stock Before the Huge Investor Update? | PATH Stock Analysis

SUMMARY

Parkev Tatevosian, CFA, provides an in-depth analysis of UiPath's recent performance, highlighting its revenue growth, operational improvements, and competitive risks from artificial intelligence. He discusses the company's valuation, management changes, and offers guidance on timing investment decisions ahead of the upcoming earnings report.

MAIN POINTS

• UiPath stock has risen over 52% in the past three months but remains down 3% for the year, with an upcoming quarterly financial report scheduled. [0:00]
• The main risk identified is AI competition, but UiPath is integrating AI into its offerings and has grown revenue to $1.67 billion, quadrupling since 2020. [1:03]
• Operating profit margins have improved from -150% in 2020 to 6.3%, with founder Daniel Dines returning as CEO and driving performance gains. [2:00]
• Despite a higher valuation, UiPath trades at a forward P/E of 17.5, with the enterprise automation landscape changing due to agentic AI. [3:00]
• A discounted cash flow update places UiPath's intrinsic value at $18.64 per share, suggesting a 17.75% upside from the current price. [4:02]
• Given potential risks in the upcoming earnings, the recommendation is to wait until after the report to consider buying UiPath shares. [5:02]

DETAILED ANALYSIS

UiPath has experienced a notable resurgence, with its stock price climbing over 52% in the last quarter, although it remains slightly negative for the year. The company is preparing to release its quarterly financial results, prompting investors to reassess its attractiveness as a buying opportunity. Recent financial updates reveal robust 17% revenue growth and significant operational efficiencies, with operating profit margins improving by 2.5 percentage points.

This performance marks a dramatic turnaround from 2020, when UiPath generated $400 million in revenue and operated at a negative 150% profit margin. Now, annual revenue stands at $1.67 billion and profit margins have turned positive at 6.3%. Returns on invested capital have also improved, reaching 16.91%, which exceeds the company's weighted average cost of capital, indicating value creation for shareholders.

A key development has been the return of founder Daniel Dines to the CEO role, after a brief period away. His leadership is credited with accelerating revenue growth and improving operational metrics. Despite the recent stock rally, UiPath's valuation remains relatively low, trading at a forward price-to-earnings ratio of 17.5, which is at the lower end of its historical range.

However, the competitive landscape has evolved rapidly, with the rise of agentic AI posing a significant threat to UiPath's core robotic process automation business. Enterprises are increasingly evaluating whether to continue with UiPath or adopt proprietary AI-driven automation solutions, making future growth less certain.

A refreshed discounted cash flow analysis estimates UiPath's intrinsic value at $18.64 per share, compared to a market price of $15.83, implying a potential upside of 17.75% over the next 12 to 18 months. Despite maintaining a buy rating throughout the year, the analysis suggests caution around the upcoming earnings release. If revenue growth slows or guidance weakens, the stock could face substantial downside due to heightened investor sensitivity to AI-related risks.

As a result, the recommendation is to wait until after the earnings announcement before considering new investments in UiPath.

LINKS

• YouTube channel membership for exclusive perks and early access.
• Special offer for The Motley Fool Stock Advisor.
• Parkev Tatevosian's book on a six-step investing framework.
• Fiscal.ai investment research platform with a discount for viewers.
• Webull investing platform sign-up with bonus shares.
• Substack monthly newsletter subscription.

KEYWORDS